Teresa Helsten Selected Research

Teresa Helsten Research Topics

12	Breast Neoplasms (Breast Cancer) 03/2024 - 05/2011
11	Neoplasms (Cancer) 01/2024 - 09/2014
3	Pathologic Complete Response 11/2021 - 01/2020
2	Residual Neoplasm 11/2021 - 07/2016
1	Bone Diseases (Bone Disease) 01/2021
1	Disease Progression 01/2021
1	Triple Negative Breast Neoplasms 01/2020
1	Retinoblastoma (Glioblastoma, Retinal) 01/2016
1	Neoplasm Metastasis (Metastasis) 09/2014
1	Acquired Immunodeficiency Syndrome (AIDS) 05/2011

4	Paclitaxel (Taxol)FDA LinkGeneric 03/2024 - 01/2021
4	Hormones (Hormone)IBA 01/2021 - 07/2016
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2021 - 05/2011
2	Trastuzumab (Herceptin)FDA Link 11/2021 - 07/2016
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2021 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2020
1	AntigensIBA 01/2024
1	Monoclonal AntibodiesIBA 01/2024
1	taxaneIBA 01/2024
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2021
1	pertuzumabIBA 11/2021
1	Ado-Trastuzumab EmtansineIBA 11/2021
1	veliparibIBA 01/2021
1	exemestane (Aromasin)FDA Link 01/2021
1	abemaciclibIBA 01/2021
1	Fulvestrant (Faslodex)FDA Link 01/2021
1	Letrozole (Femara)FDA LinkGeneric 01/2021
1	Anastrozole (Arimidex)FDA LinkGeneric 01/2021
1	PlatinumIBA 01/2021
1	Tamoxifen FDA LinkGeneric 01/2021
1	Carboplatin (JM8)FDA LinkGeneric 01/2021
1	Aromatase InhibitorsIBA 01/2021
1	MK 2206IBA 01/2020
1	ErbB Receptors (EGF Receptor)IBA 01/2020
1	TOR Serine-Threonine KinasesIBA 01/2020
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2020
1	pembrolizumabIBA 01/2020
1	Circulating Tumor DNAIBA 01/2019
1	neratinibIBA 07/2016
1	regorafenibIBA 09/2015
1	ponatinibIBA 09/2015
1	LigandsIBA 09/2015
1	lenvatinibIBA 09/2015
1	pazopanib FDA Link 09/2015
1	Methotrexate (Mexate)FDA LinkGeneric 09/2014
1	Cytarabine (Cytosar-U)FDA LinkGeneric 09/2014
1	Zolpidem (Ambien)FDA LinkGeneric 05/2011
1	Lorazepam (Ativan)FDA LinkGeneric 05/2011

9	Therapeutics 01/2024 - 11/2015
6	Neoadjuvant Therapy 11/2021 - 05/2011
5	Drug Therapy (Chemotherapy) 11/2021 - 05/2011
2	Adjuvant Chemotherapy 01/2020 - 05/2011
1	Investigational Therapies (Experimental Therapy) 11/2021